Hims & Hers officer plans sale of 12,313 shares

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) received a Rule 144 notice from an officer, Oluyemi Okupe, covering a proposed sale of up to 12,313 Class A shares through Fidelity Brokerage Services LLC, with an aggregate market value of $354,860.66 and an intended sale date of September 17, 2026 on the NYSE.

The shares were acquired on August 15, 2026 via Restricted Stock Vesting from the issuer as compensation. Shares of Class A common stock outstanding were 224,935,790 as of September 17, 2026; this is a baseline figure, not the amount being sold.

Key Figures

Shares covered by Form 144: 12,313 shares Aggregate market value of shares: $354,860.66 Shares outstanding: 224,935,790 shares +2 more

5 metrics

Shares covered by Form 144 12,313 shares Class A shares proposed for sale under Rule 144 by officer Oluyemi Okupe

Aggregate market value of shares $354,860.66 Market value associated with 12,313 Class A shares covered by the notice

Shares outstanding 224,935,790 shares Class A common stock outstanding as of September 17, 2026

Intended sale date September 17, 2026 Stated date of proposed sale of the 12,313 shares

Acquisition date of shares August 15, 2026 Date the 12,313 shares were acquired via Restricted Stock Vesting

Key Terms

Rule 144, Restricted Stock Vesting, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Class A | 08/15/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Oluyemi Okupe"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for HIMS disclose?

The filing discloses that an officer, Oluyemi Okupe, has filed a Rule 144 notice covering a potential sale of 12,313 Class A shares of Hims & Hers Health, Inc. through Fidelity Brokerage Services LLC.

How many HIMS shares are covered by this Form 144 notice?

The notice covers up to 12,313 Class A shares of Hims & Hers Health, Inc. These shares are proposed to be sold through Fidelity Brokerage Services LLC under Rule 144.

What is the reported market value of the HIMS shares in this Form 144?

The aggregate market value of the HIMS shares covered by the notice is reported as $354,860.66, corresponding to the 12,313 Class A shares referenced in the Form 144.

When were the HIMS shares in this Form 144 acquired and how?

The 12,313 Class A shares were acquired on August 15, 2026 via Restricted Stock Vesting from Hims & Hers Health, Inc., with the consideration described as compensation.

How many HIMS shares were outstanding compared to the Form 144 amount?

Class A common shares outstanding were 224,935,790 as of September 17, 2026. The Form 144 covers 12,313 shares, which is a small portion of this outstanding share count.

On which exchange are the HIMS shares in this Form 144 planned to be sold?

The Form 144 states that the 12,313 Class A shares of Hims & Hers Health, Inc. are intended to be sold on the NYSE, with Fidelity Brokerage Services LLC listed as broker.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 03:55 PM Accepted by SEC EDGAR 09/17/2026 - 03:55 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001907056
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hims & Hers Health, Inc.
SEC File Number	001-38986
Address of Issuer	2269 CHESTNUT ST #523 SAN FRANCISCO CALIFORNIA 94123
Phone	415-851-0195
Name of Person for Whose Account the Securities are To Be Sold	Okupe Oluyemi
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	12313	354860.66	224935790	09/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	08/15/2026	Restricted Stock Vesting	Issuer			12313	08/15/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Oluyemi Okupe
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)